As of the end of the quarter Ubs Asset Management Americas Inc had bought 745 shares growing its holdings by 2,191.2%. Hedge funds and other institutional investors own 82.05% of the company's stock. DekaBank Deutsche Girozentrale bought a new position in Hill-Rom Holdings during the third quarter worth approximately $106,000. Acrospire Investment Management LLC increased its position in Hill-Rom Holdings by 43.4% during the 2nd quarter. Olstein Capital Management, L.p. claims 88,780 shares with a value of $6,570,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Hill-Rom Holdings by 10.2% during the 2nd quarter. Insiders own 2.20% of the company's stock. The value of the company's investment in Hill-Rom Holdings Inc went from $9,765,000 to $9,974,000 a change of $209,000 quarter to quarter.
Los Angeles Capital Management & Equity Research Inc. decreased its position in Hill-Rom Holdings Inc. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,201 shares of the medical technology company's stock worth $175,000 after purchasing an additional 204 shares in the last quarter.
The company is trading up by 0.55% since yesterday's close of 76.18. The firm owned 6,297 shares of the medical technology company's stock after selling 300 shares during the period. The company has a market cap of $3.85 billion, a PE ratio of 31.49 and a beta of 1.15. Following the transaction, the chief operating officer now owns 22,163 shares in the company, valued at approximately $1,214,089.14. Hill-Rom Holdings Inc. has a 1-year low of $42.99 and a 1-year high of $63.12.
Hill-Rom Holdings (HRC) traded up $0.55 during midday trading on Tuesday, reaching $76.73. The company's revenue was up 23.0% compared to the same quarter previous year. The firm had revenue of $738.30 million during the quarter, compared to the consensus estimate of $731.10 million. Hill-Rom Holdings had a net margin of 4.87% and a return on equity of 20.27%.
The company also recently declared a quarterly dividend, which will be paid on Friday, December 29th. Stockholders of record on Friday, December 16th were paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date of this dividend was Wednesday, December 14th. Hill-Rom Holdings's dividend payout ratio is now 36.18%. The shares were sold at an average price of $77.48, for a total value of $532,287.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
In other news, COO Carlyn D. Solomon sold 40,515 shares of the business's stock in a transaction that occurred on Thursday, November 17th. The stock was sold at an average price of $77.84, for a total transaction of $306,689.60. Following the transaction, the senior vice president now directly owns 16,701 shares of the company's stock, valued at approximately $1,300,005.84. The disclosure for this sale can be found here.
Several equities analysts recently commented on HRC shares. July 30 investment analysts at Stifel Nicolaus left the company rating at "Buy" projecting a price of $84.00. Needham & Company LLC dropped their price objective on Hill-Rom Holdings from $95.00 to $93.00 and set a "buy" rating for the company in a research report on Friday, July 28th.
Barclays PLC raised the price target on November 6 changing the forecast from $86.00 to $90.00 with a rating of "Overweight". Stifel Nicolaus raised the price target on November 6 boosting the projection from $84.00 to $85.00 with a rating of "Buy". Finally, Zacks Investment Research lowered shares of Hill-Rom Holdings from a "hold" rating to a "sell" rating in a report on Wednesday, August 2nd. On November 5 KeyCorp maintained a company rating of "Buy" with a current price target of $89.00.
TRADEMARK VIOLATION NOTICE: This news story was posted by TrueBlueTribune and is owned by of TrueBlueTribune. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & global trademark & copyright law.
Traders are more bullish on Hill-Rom Holdings Inc lately considering the fall in short interest. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas.